An overgrowth of nerve cells appears to cause lingering symptoms after recurrent UTIs
A perplexing problem for people with recurring urinary tract infections (UTIs) is persistent pain, even after antibiotics have successfully cleared the bacteria.
Noticias
New antibodies target ‘dark side’ of influenza virus protein
Researchers at the National Institutes of Health have identified antibodies targeting a hard-to-spot region of the influenza virus, shedding light on the relatively unexplored “dark side” of the neuraminidase (NA) protein head. The antibodies target a …
The surprisingly complex inner workings of an endocrine tumor
There is strength in teamwork, and it turns out that this applies to tumors, too. Researchers from Japan have reported that different types of cells within a single benign tumor may work together to promote the tumor’s growth.
Combining CAR-T cells and inhibitor drugs for high-risk neuroblastoma
Chimeric antigen receptor (CAR)-T cell therapy is a potent emerging weapon against cancer, altering patients’ T cells so they can better find and destroy tumor cells. But CAR-T cell therapy doesn’t work well in every cancer—including many cases of neur…
New microbiome insights could help boost immunotherapy for a range of rare cancers
The microbiome can identify those who benefit from combination immunotherapy across multiple different cancers, including rare gynecological cancers, biliary tract cancers and melanoma.
COVID-19: A potential treatment for loss of smell
One of the most persistent and debilitating symptoms of COVID-19 is anosmia or loss of smell. Researchers at INRAE and ENVA have discovered that a corticoid treatment could help restore the olfactory capacities affected by the viral infection. These re…
Targeted immunotherapy could lead to pioneering treatment for breast cancer
A new type of immunotherapy that targets non-cancer cells could help prevent the growth and spread of breast cancer tumors, according to new research.
A safer treatment path for high-risk children to overcome food allergies
New research from the University of British Columbia reveals a safe path to overcoming food allergies for older children and others who can’t risk consuming allergens orally to build up their resistance.
Researcher discusses turbocharging CRISPR to understand how the immune system fights cancer
Over the past two decades, the immune system has attracted increasing attention for its role in fighting cancer. As researchers have learned more and more about the cancer-immune system interplay, several antitumor immunotherapies have become FDA-appro…
Immunotherapy combination may benefit patients with transplanted kidneys and advanced skin cancers
People who have had a kidney transplant are at high risk for developing skin cancers. New research directed by investigators from the Johns Hopkins Kimmel Cancer Center is exploring the best combination of treatments to target skin cancers while preser…